Scotland moves to prioritise cancer surgery amid COVID-19 ‘recovery’ Premium Content News News, Cancer, All oncology, Oncology Room Scotland moves to prioritise cancer surgery amid COVID-19 ‘recovery’ OnMedica Jun 05, 2020
Isatuximab in combination not recommended for multiple myeloma Premium Content NICE guidance Drug and Therapeutics Update, All oncology, Haematological malignancies, Oncology Room Isatuximab in combination not recommended for multiple myeloma OnMedica Jun 04, 2020
2.4 people million caught up in COVID-19 cancer care backlog Premium Content News News, Cancer, All oncology, Oncology Room 2.4 people million caught up in COVID-19 cancer care backlog OnMedica Jun 02, 2020
Prostate cancer now most common cancer diagnosis in UK Premium Content News News, Cancer, All oncology, Genitourinary cancers, Oncology Room Prostate cancer now most common cancer diagnosis in UK OnMedica Jun 02, 2020
Mass genetic screening for prostate cancer - feasible Premium Content News News, Cancer, All oncology, Genitourinary cancers, Oncology Room Mass genetic screening for prostate cancer - feasible OnMedica Jun 01, 2020
Promising new treatment for glioblastoma Premium Content News News, Cancer, Neuro-oncology, Oncology Room Promising new treatment for glioblastoma OnMedica May 28, 2020
New treatment approved for small-cell lung cancer Premium Content News News, Cancer, All oncology, Thoracic cancer , Oncology Room New treatment approved for small-cell lung cancer OnMedica May 28, 2020
Oncology – Journal Spy Journal Spy, Oncology Room Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression. ClinOwl May 22, 2020
Oncology – Journal Spy Journal Spy, Oncology Room Management of Cancer Cachexia: ASCO Guideline. ClinOwl May 20, 2020
How coronavirus is impacting cancer services in the UK Premium Content Features and Comments, Cancer, All oncology, Oncology Room How coronavirus is impacting cancer services in the UK Cancer Research UK May 11, 2020
Oncology – Journal Spy Journal Spy, All oncology, Oncology Room Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial. ClinOwl Apr 30, 2020
Premium Content Cancer, All oncology, Oncology Room Coronavirus and cancer services OnMedica Apr 22, 2020
Why diagnostics is the next big challenge for NHS cancer services Premium Content Features and Comments, Cancer, All oncology, Oncology Room Why diagnostics is the next big challenge for NHS cancer services OnMedica Apr 22, 2020
Call for all cancer patients and staff to be tested for COVID-19 Premium Content News News, Cancer, All oncology, Oncology Room Call for all cancer patients and staff to be tested for COVID-19 OnMedica Apr 20, 2020
Pancreatic cancer cells use the same energy as sprinters’ muscles to spread Premium Content Features and Comments, Cancer, All oncology, Gastrointestinal cancer, Oncology Room Pancreatic cancer cells use the same energy as sprinters’ muscles to spread Cancer Research UK Apr 09, 2020
Oncology – Journal Spy Journal Spy, Oncology Room JSCO/ ESMO/ ASCO/ JSMO/ TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions. ClinOwl Apr 09, 2020
Liquid biopsy has prognostic role in colorectal cancer and potential for guiding therapy Premium Content ESMO Congress News, Gastrointestinal cancer, Oncology Room Liquid biopsy has prognostic role in colorectal cancer and potential for guiding therapy OnMedica Dec 09, 2019
AI blood test can spot signs of brain tumour to speed up diagnosis Premium Content NCRI Cancer Conference News, Cancer, All oncology, Neuro-oncology, Oncology Room AI blood test can spot signs of brain tumour to speed up diagnosis OnMedica Nov 04, 2019
New studies question whether novel anti-cancer drugs are worth their extra cost Premium Content ESMO Congress News, All oncology, Oncology Room New studies question whether novel anti-cancer drugs are worth their extra cost OnMedica Oct 11, 2019
ASCO 2019 Premium Content Features and Comments, Oncology Room ASCO 2019 Cancer Research UK Jun 14, 2019
